Sumatriptan and Belsomra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sumatriptan (sumatriptan succinate) and Belsomra (suvorexant). Common drug interactions include alopecia among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Sumatriptan and Belsomra. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Sumatriptan?

Sumatriptan has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 18,159 Sumatriptan users. Check the latest studies of Sumatriptan.

What is Belsomra?

Belsomra has active ingredients of suvorexant. It is often used in insomnia. eHealthMe is studying from 12,961 Belsomra users. Check the latest studies of Belsomra.

On Jul, 08, 2026

32 people who take Sumatriptan and Belsomra together, and have interactions are studied.

Sumatriptan and Belsomra drug interactions.

What are the common drug interactions of Sumatriptan and Belsomra, by gender? *:

female:

Alopecia (absence of hair from areas of the body)
Stress
Muscle spasms (muscle contraction)
Nausea (feeling of having an urge to vomit)
Fall
Contusion (a type of hematoma of tissue in which capillaries)
Dizziness
Fatigue (feeling of tiredness)
Abnormal behaviour
Agitation (state of anxiety or nervous excitement)

male:

Anxiety
Chronic kidney disease
Emotional distress
Pain
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Dermatitis allergic (inflammation of the skin due allergic reaction)
Drug ineffective
Renal failure (kidney dysfunction)
Renal tubular necrosis (death of kidney tubules)
Stem cell transplant

What are the common drug interactions of Sumatriptan and Belsomra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Hospitalisation

20-29:

n/a

30-39:

Anaphylactic reaction (serious allergic reaction)
Hypersensitivity
Pregnancy
Rash pruritic (redness with itching)
Weight increased

40-49:

Alopecia (absence of hair from areas of the body)
Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)
Headache (pain in head)
Blood glucose decreased
Chronic kidney disease
Decreased appetite
Dermatitis allergic (inflammation of the skin due allergic reaction)
Dizziness
Drug ineffective

50-59:

Abnormal behaviour
Agitation (state of anxiety or nervous excitement)
Alopecia (absence of hair from areas of the body)
Asthma
Blood pressure increased
Breast cyst
Chronic fatigue syndrome (disorder that causes extreme fatigue)
Constipation
Cytomegalovirus infection
Dehydration (dryness resulting from the removal of water)

60+:

Cataract (clouding of the lens inside the eye)
Cellulitis (infection under the skin)
Hip arthroplasty
Muscle spasms (muscle contraction)
Uterine disorder
Chronic kidney disease
Fatigue (feeling of tiredness)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 13 people, 40.62%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 18.75%
Pain: 3 people, 9.38%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 9.38%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 9.38%
Drowsiness: 3 people, 9.38%
Stress And Anxiety: 2 people, 6.25%
Immunodeficiency Common Variable: 2 people, 6.25%
Hiv Infection: 2 people, 6.25%
High Blood Pressure: 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan and Belsomra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously